I think if the results are strong enough the Safety Committee deems it necessary to stop the trial (as I believe it will be) and the efficacy data from the MM trial proves statistical significance (which I also believe it will based on the safety data and the exuberant smiles), no one is going to have to be convinced. Everyone is waiting for data. The medical community, particularly clinicians who are losing patients, and dealing with hell in overcrowded ICUs, government, businesses, regular people. Every wants a treatment, a cure, a prophylactic, a vaccine, whatever works and is safe! India has given EAU to a MAB drug which works similarly to leronlimab and Cuba has been using that drug for months with a low death rate, despite high incidence of co-morbidity in Cuba. I can't imagine that anyone's arm needs to be twisted at this point: we are almost at 150,000 deaths here.